-
NJATOD 2024 in Review
Reflecting on Achievements and Looking Ahead: NJATOD’s Journey Through 2024 As we close another remarkable year, we are pleased to […]
-
Urgent Public Health Alert: Rise in Medetomidine Exposure in New Jersey
Public Health Alert NJLINCS Health Alert Network Distributed by the New Jersey Department of Health Increase in Suspected Medetomidine Exposure […]
-
Why Every Business Needs Long-Term Disability Insurance
HERE’S WHY YOU NEED LONG-TERM DISABILITY INSURANCE The no-brainer benefit for business owners Business owners of all sizes are saddled […]
-
NJATOD Calls for State Action on New Federal Opioid Treatment Standards
Explore NJATOD’s latest advocacy efforts detailed in our comprehensive letter addressing the 42 CFR Part 8 Final Rule. This crucial document outlines our proposed recommendations and urgent requests to state regulators, aiming to align federal and state policies to enhance opioid treatment programs in New Jersey. Discover how these changes can significantly improve treatment outcomes and regulatory processes
-
New Jersey Passes Law to Prevent Monetary Incentives for Patients Referred to Substance Abuse Treatment Facilities
On March 1, 2021, New Jersey Governor Philip Murphy signed Assembly Bill No. 2280 into law to prevent “recruiters” from substance abuse treatment facilities to refer or entice any patient using monetary or other incentives to enter treatment.
